Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revolutionizing cancer drug development: Harnessing the potential of basket trials.

Cancer - 1 Jan 2024

Subbiah Vivek, Burris Howard A, Kurzrock Razelle

Abstract excerpt

The landscape of cancer therapy has been transformed by advances in clinical next-generation sequencing, genomically targeted therapies, and immunotherapies. Well designed clinical trials and efficient clinical trial conduct are crucial for advancing our understanding of cancer, improving patient outcomes, and identifying personalized treatments. Basket trials have emerged as one of the efficient modern clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Drug Development

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Source

Identifiers

PMID: 37934000
DOI: 10.1002/cncr.35085

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revolutionizing cancer drug development: Harnessing the potential of basket trials.PMID 37934000Read ↗

Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkersSemantic proximity Read ↗

Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven OncologySemantic proximity Read ↗

The Bayesian basket design for genomic variant-driven phase II trials.Semantic proximity Read ↗

Comparing the efficacy of cancer therapies between subgroups in basket trialsSemantic proximity Read ↗

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.Semantic proximity Read ↗

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.Semantic proximity Read ↗

An efficient basket trial design.Semantic proximity Read ↗

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.Semantic proximity Read ↗

Characterization of Oncology Clinical Trials Using Germline Genetic DataSemantic proximity Read ↗

Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.Semantic proximity Read ↗

Designing Transformative Clinical Trials in the Cancer Genome EraSemantic proximity Read ↗

Novel clinical trial designs emerging from the molecular reclassification of cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.